• $28.7M
    Market Cap
  • -37.18%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
ARMISTICE CAPITAL, LLC
9.32%
4.0M
-123,780 (-3.11%)
Jun 30, 2026
VANGUARD CAPITAL MANAGEMENT LLC
0.98%
416,852
+34,383 (+8.25%)
Jun 30, 2026
N/A
0.90%
382,469
+382,469 (+100.00%)
Mar 31, 2026
GEODE CAPITAL MANAGEMENT, LLC
0.33%
141,321
-16,164 (-11.44%)
Jun 30, 2026
VANGUARD FIDUCIARY TRUST CO
0.15%
64,921
0 (0.00%)
Jun 30, 2026
BLACKROCK, INC.
0.12%
52,033
+12,143 (+23.34%)
Jun 30, 2026
STATE STREET CORP
0.10%
43,252
0 (0.00%)
Jun 30, 2026

Current Ownership Distribution

  • Insiders26.3M (61.60%)
  • Institutions10.4M (24.27%)
  • Mutual Funds3.1M (7.31%)
  • Other2.9M (6.82%)

Insider Transactions

  • 61.60% (26.3M)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 0
    Number of InsiderSelling (last 12 months)
  • $0.00
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Liu Cheng
CEO
Exempt
Aug 25, 2026
$0.00
100,000
$0.00
900,000
Liu Cheng
CEO
Exempt
Aug 25, 2026
$81,500.00
100,000
$0.81
397,437
Xu Jiandong
Chief Financial Officer
Exempt
Aug 18, 2026
$0.00
100,000
$0.00
390,796
Xu Jiandong
Chief Financial Officer
Exempt
Aug 18, 2026
$81,500.00
100,000
$0.81
365,488
Xu Jiandong
Chief Financial Officer
Award
Oct 30, 2024
$0.00
490,796
$0.00
490,796
Liu Cheng
Chief Executive Officer
Award
Oct 30, 2024
$0.00
490,796
$0.00
490,796
Xu Jiandong
Chief Financial Officer
Award
Oct 30, 2024
$0.00
509,204
$0.00
509,203
Liu Cheng
Chief Executive Officer
Award
Oct 30, 2024
$0.00
509,204
$0.00
509,203